BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23044390)

  • 1. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
    Frommeyer G; Kaiser D; Uphaus T; Kaese S; Osada N; Rajamani S; Belardinelli L; Breithardt G; Eckardt L; Milberg P
    Heart Rhythm; 2012 Dec; 9(12):2051-8. PubMed ID: 23044390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
    Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
    Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
    Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
    J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological profile of vernakalant in an experimental whole-heart model: the absence of proarrhythmia despite significant effect on myocardial repolarization.
    Frommeyer G; Milberg P; Clauss C; Schmidt M; Ramtin S; Kaese S; Grundmann F; Grotthoff JS; Pott C; Eckardt L
    Europace; 2014 Aug; 16(8):1240-8. PubMed ID: 24696223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.
    Milberg P; Frommeyer G; Uphaus T; Kaiser D; Osada N; Breithardt G; Eckardt L
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):92-100. PubMed ID: 21964157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.
    Milberg P; Pott C; Frommeyer G; Fink M; Ruhe M; Matsuda T; Baba A; Klocke R; Quang TH; Nikol S; Stypmann J; Osada N; Müller FU; Breithardt G; Noble D; Eckardt L
    Heart Rhythm; 2012 Apr; 9(4):570-8. PubMed ID: 22075452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
    Frommeyer G; Milberg P; Witte P; Stypmann J; Koopmann M; Lücke M; Osada N; Breithardt G; Fehr M; Eckardt L
    Eur J Heart Fail; 2011 Oct; 13(10):1060-9. PubMed ID: 21873342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedarone.
    Frommeyer G; Puckhaber D; Ellermann C; Dechering DG; Kochhäuser S; Leitz P; Reinke F; Eckardt L
    Int J Cardiol; 2017 Feb; 228():74-79. PubMed ID: 27863364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model.
    Sossalla S; Wallisch N; Toischer K; Sohns C; Vollmann D; Seegers J; Lüthje L; Maier LS; Zabel M
    Cardiovasc Ther; 2014 Aug; 32(4):170-7. PubMed ID: 24785406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.
    Frommeyer G; Weller J; Ellermann C; Leitz P; Kochhäuser S; Lange PS; Dechering DG; Eckardt L
    Cardiovasc Toxicol; 2019 Apr; 19(2):129-135. PubMed ID: 30238354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of D-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart.
    Zabel M; Hohnloser SH; Behrens S; Woosley RL; Franz MR
    J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1239-45. PubMed ID: 9395166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
    Milberg P; Ramtin S; Mönnig G; Osada N; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):278-86. PubMed ID: 15475823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
    Frommeyer G; von der Ahe H; Brücher B; Dechering DG; Lange PS; Reinke F; Wasmer K; Köbe J; Pott C; Mönnig G; Eckardt L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1073-80. PubMed ID: 27405774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronedarone and digitalis: individually reduced post-repolarization refractoriness enhances life-threatening arrhythmias.
    Frommeyer G; Milberg P; Schulze Grotthoff J; Dechering DG; Kochhäuser S; Stypmann J; Fehr M; Breithardt G; Eckardt L
    Europace; 2015 Aug; 17(8):1300-8. PubMed ID: 25713011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effect of vernakalant in an experimental model of Long-QT-syndrome.
    Frommeyer G; Clauss C; Ellermann C; Bogossian H; Dechering DG; Kochhäuser S; Reinke F; Pott C; Eckardt L
    Europace; 2017 May; 19(5):866-873. PubMed ID: 27702859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia.
    Verrier RL; Pagotto VP; Kanas AF; Sobrado MF; Nearing BD; Zeng D; Belardinelli L
    Heart Rhythm; 2013 Jan; 10(1):121-7. PubMed ID: 22985658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
    Burashnikov A; Di Diego JM; Barajas-Martínez H; Hu D; Cordeiro JM; Moise NS; Kornreich BG; Belardinelli L; Antzelevitch C
    Circ Heart Fail; 2014 Jul; 7(4):627-33. PubMed ID: 24874201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.